Esperion-2026-JPM.pdf

1、Executing Today While Building for Tomorrow 2025 Esperion Therapeutics,Inc.All rights reserved.J.P.Morgan Healthcare Conference I January 2026Sheldon Koenig,President and CEOForward-looking Statements&DisclosuresThis investor presentation contains forward-looking statements that are made pursuant to

2、 the safe harbor provisions of the federal securities laws,including statements regarding marketing strategy and commercialization and business development plans,current and planned operational expenses,expected profitability,future operations,commercial products,clinical development,plans for poten

3、tial future product candidates,financial condition and outlook,including expected cash runway and profitability,and other statements containing the words“anticipate,”“believe,”“estimate,”“expect,”“intend,”“may,”“plan,”“predict,”“project,”“suggest,”“target,”“potential,”“will,”“would,”“could,”“should,

4、”“continue,”and similar expressions.Any express or implied statements contained in this investor presentation that are not statements of historical fact may be deemed to be forward-looking statements.Forward-looking statements involve risks and uncertainties that could cause Esperions actual results

5、 to differ significantly from those projected,including,without limitation,the net sales,profitability,and growth of Esperions commercial products,clinical activities and results,supply chain,commercial development and launch plans,business development,the outcomes and anticipated benefits of legal

6、proceedings and settlements,and the risks detailed in Esperions filings with the Securities and Exchange Commission.Any forward-looking statements contained in this investor presentation speak only as of the date hereof,and Esperion disclaims any obligation or undertaking to update or revise any for